Plus Therapeutics, Inc. Financial Ratios — PSTV Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-197.76	-393.62	-546.09	- -	- -	-190.12	-222.32	-138.64	-341.02	-393.27	-193.25	-234.65	- -	- -	- -
Return on Assets (%)	-55.06	-68.11	-61.37	-92.52	-49.06	-60.98	-68.51	-45.44	-46.11	-46.65	-78.62	-88.44	-75.54	-144.03	-195.02
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	61.61	72.42	71.95	61.31	72.67	80.93	79.44	61.52	100	100	- -	- -	- -	- -	- -
EBITDA Margin (%)	-321.9	-188.64	-260.06	-421.52	-187.5	-162.78	-289.07	-226.55	-39.45	-3,042.24	- -	- -	- -	- -	- -
Operating Margin (%)	-330.45	-195.07	-273.43	-431.77	-196.88	-173.16	-322.62	-293.73	-52.26	-3,163.04	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	937.95	- -	- -	- -	- -
Pretax Margin (%)	-324.64	-222.6	-214.64	-491.81	-160.77	-193.73	-353.86	-297.62	-46.91	-2,719.8	- -	- -	- -	- -	- -
Profit Margin (%)	-324.64	-222.6	-214.64	-491.81	-160.77	-193.73	-353.86	-423.53	-155.57	-2,719.8	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-324.64	-222.6	-214.64	-507.2	-166.44	-193.73	-415.89	-423.53	-155.57	-2,719.8	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	3.03	3.02	- -	14.92	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-197.76	-393.62	-546.09	- -	- -	-190.12	-189.16	-138.64	-341.02	-393.27	-193.25	-234.65	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	24	23	26	25	18	18	14	14	12	7	7	6	4	3	1
ST Debt	2	10	3	7	2	7	14	14	11	6	2	2	4	3	1
LT Debt	22	13	23	18	17	11	- -	- -	1	1	5	4	- -	- -	- -
Total Debt/EBITDA	-0.76	-0.83	-0.83	-0.79	-0.84	-0.95	-0.74	-2.1	-4.34	-0.76	-0.58	-0.3	-0.33	-0.24	-0.06
Net Debt/EBITDA	0.39	0.11	-0.34	-0.34	-0.19	-0.27	-0.22	-1.32	2.35	0.22	0.98	0.67	0.36	-0.23	0.24
Total Debt/EBIT	-0.74	-0.8	-0.79	-0.77	-0.8	-0.9	-0.66	-1.62	-3.27	-0.73	-0.56	-0.29	-0.31	-0.23	-0.05
Net Debt/EBIT	0.38	0.11	-0.32	-0.33	-0.18	-0.26	-0.2	-1.02	1.78	0.21	0.95	0.65	0.34	-0.22	0.23
EBITDA to Interest Expense	-11.56	-8.08	-9.34	-7.33	-6.47	-7.15	-9.04	-3.52	-1.49	-8.33	-12.91	-26.85	-32.13	-3.71	-4.12
EBITDA-CapEx/Interest Expense	-11.76	-8.43	-9.73	-7.56	-6.65	-7.17	-9.77	-3.59	-1.52	-8.77	-13.06	-27.92	-32.54	-3.9	-4.13
EBIT to Interest Expense	-11.86	-8.35	-9.82	-7.51	-6.79	-7.6	-10.09	-4.56	-1.97	-8.66	-13.33	-27.72	-33.72	-3.95	-4.24
Interest Expense	3	3	3	4	3	3	2	2	2	1	1	1	- -	4	4
Common Equity/Total Assets	19.3	14.92	7.45	-14.73	32.38	31.74	41.12	21.78	4.99	25.04	49.3	27	-11.84	-134.92	24.48
Long-Term Debt/Equity (%)	220.81	199.89	737.55	- -	136.66	100.2	- -	- -	55.69	17.42	48.67	60.93	- -	- -	0.38
Long-Term Debt/Capital (%)	63.85	44.28	78.51	91.57	54.45	38.46	- -	- -	4.92	5.27	29.58	32.48	3	-0.56	0.31
Long-Term Debt/Total Assets (%)	42.62	29.83	54.92	46.59	44.25	31.81	- -	- -	2.78	4.36	23.99	16.45	0.75	0.47	0.09
Total Debt/Equity (%)	245.82	351.46	839.43	-445.53	151	160.54	104.8	271.81	1,032.16	230.81	64.53	87.59	-310.16	-37.62	20.55
Total Debt/Capital (%)	71.08	77.85	89.36	128.94	60.16	61.62	51.17	73.1	91.17	69.77	39.22	46.69	147.58	-60.32	17.04
Total Debt/Total Assets (%)	47.44	52.46	62.51	65.61	48.89	50.96	43.09	59.2	51.54	57.79	31.81	23.65	36.71	50.76	5.03
Net Debt to Equity	-125.41	-46.94	344.35	-189.09	33.53	46.21	31.34	171.12	-559.66	-66.35	-108.78	-197.46	339.61	-35.94	-87.74
Net Debt/Capital (%)	493.59	-88.47	77.5	212.24	25.11	31.61	23.86	63.12	146.91	-119.63	2,064.27	211.04	80.02	-56.84	-624.96
EBITDA	-32	-27	-32	-32	-22	-19	-19	-7	-3	-9	-12	-19	-13	-14	-15
EBITDA-CapEx	-33	-29	-33	-33	-22	-19	-20	-7	-3	-10	-12	-20	-13	-15	-15
Operating Income (Loss)	-33	-28	-33	-33	-23	-20	-21	-9	-4	-10	-12	-20	-13	-15	-15

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.72	1.46	1.04	0.92	1.7	1	0.52	0.3	1.21	0.98	3.13	1.53	0.8	0.23	0.7
Current Ratio	5.54	1.93	1.65	1.36	2.52	1.5	0.81	0.55	1.37	1.07	3.36	1.84	0.92	0.34	1.23
Quick Ratio	5.04	1.69	1.33	1	1.85	1.11	0.53	0.31	1.3	0.98	3.14	1.53	0.8	0.27	0.73
CFO/Avg Current Liab	-3.36	-2.53	-2.13	-1.97	-1.68	-1.87	-1.17	-0.67	-0.37	-0.73	-1.43	-1.46	-1.14	-0.8	-1.49
Common Equity/Total Assets	19.3	14.92	7.45	-14.73	32.38	31.74	41.12	21.78	4.99	25.04	49.3	27	-11.84	-134.92	24.48
Long-Term Debt/Equity (%)	220.81	199.89	737.55	- -	136.66	100.2	- -	- -	55.69	17.42	48.67	60.93	- -	- -	0.38
Long-Term Debt/Capital (%)	63.85	44.28	78.51	91.57	54.45	38.46	- -	- -	4.92	5.27	29.58	32.48	3	-0.56	0.31
Long-Term Debt/Total Assets (%)	42.62	29.83	54.92	46.59	44.25	31.81	- -	- -	2.78	4.36	23.99	16.45	0.75	0.47	0.09
Total Debt/Equity (%)	245.82	351.46	839.43	-445.53	151	160.54	104.8	271.81	1,032.16	230.81	64.53	87.59	-310.16	-37.62	20.55
Total Debt/Capital (%)	71.08	77.85	89.36	128.94	60.16	61.62	51.17	73.1	91.17	69.77	39.22	46.69	147.58	-60.32	17.04
Total Debt/Total Assets (%)	47.44	52.46	62.51	65.61	48.89	50.96	43.09	59.2	51.54	57.79	31.81	23.65	36.71	50.76	5.03
CFO/Total Liabilities	-84.94	-87.49	-88.79	-68.28	-80.29	-82.69	-97.38	-63.81	-26.76	-92.95	-92.24	-74.46	-100.9	-67.73	-168.51
CFO/CapEx	-63.08	-26.74	-26.2	-29.76	-32.8	-291.54	-12.12	-90.04	-88.15	-17.11	-71.39	-17.09	-80.32	-15.27	-310.07
Altman's Z-Score	-6.47	-8.2	-14.73	-21.66	-21.26	-25.11	-30.12	-25.92	-25.74	-53.83	-29.28	-29.85	-65.04	-129.52	-45.79

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.61	4.69	3.02	2.82	10.16	9.92	9.24	18.47	10.39	0.52	- -	- -	- -	- -	- -
Days Sales Outstanding	79.11	77.85	120.88	129.59	35.92	36.79	39.48	19.76	35.13	704.1	- -	- -	- -	- -	- -
Inventory Turnover	1.15	1.23	1	0.69	0.7	0.54	0.38	0.7	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	318.48	296.24	366.44	529.06	522.81	674.75	956.53	523.02	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	27.77	4.17	3.1	4.26	2.71	1.36	0.59	-1.91	- -	-0.19	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	13.14	87.58	117.84	85.72	134.59	267.52	618.29	-191.02	- -	-1,903.46	- -	- -	- -	- -	- -
Cash Conversion Cycle	384.45	286.51	369.48	572.93	424.15	444.01	377.73	733.8	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	-239.37	-218.39	-245.56	-399.48	-486.89	-637.96	-917.05	-503.26	- -	- -	- -	- -	- -	- -	- -
Inventories	3	3	4	5	4	4	3	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	2	1	1	2	1	1	1	1	- -	- -	- -	- -	- -	- -	- -
Work In Process	1	- -	- -	1	1	1	1	1	- -	- -	- -	- -	- -	- -	- -
Finished Goods	1	1	2	2	2	2	2	2	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	-3	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	130	189	188	51	38	33	17	4	9	14	16	11	8	7	71
- Cash & Cash Equivalents	37	26	16	15	14	13	10	5	18	8	18	18	9	- -	4
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	24	23	26	25	18	18	14	14	12	7	7	6	4	3	1
Enterprise Value	117	186	199	62	43	38	21	13	4	12	5	-2	3	7	63
Total Capital	34	29	29	20	31	29	27	19	13	10	18	12	3	-6	5
Total Debt/Capital (%)	71.08	77.85	89.36	128.94	60.16	61.62	51.17	73.1	91.17	69.77	39.22	46.69	147.58	-60.32	17.04
Total Debt / EV	0.21	0.12	0.13	0.41	0.43	0.47	0.64	1.07	3.21	0.57	1.43	-3.28	1.23	0.51	0.01
EV/Sales	11.75	12.82	16.29	8.13	3.65	3.31	3.34	4.44	0.53	40.54	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	130	189	188	51	38	33	17	4	3	9	13	8	5	9	40
Diluted Enterprise Value	117	186	199	62	43	38	21	13	-2	8	1	-4	1	12	36
EV per Share	5,593,547.62	7,748,750	7,642,932.69	1,669,530.41	591,222.22	327,272.83	69,477.27	16,755.22	360.86	682.49	117.95	112.87	19.15	27.74	11.41
TTM Sales	10	15	12	8	12	11	6	3	7	- -	- -	- -	- -	- -	- -
TTM EBITDA	-32	-27	-32	-32	-22	-19	-19	-7	-3	-9	-12	-19	-13	-14	-15
TTM Operating Income	-33	-28	-33	-33	-23	-20	-21	-9	-4	-10	-12	-20	-13	-15	-15
TTM Cash Flow to Firm	-33	-29	-31	-26	-17	-17	-16	-10	-4	-7	-9	-12	-12	-7	-17
TTM Free Cash Flow to Firm	-32	-28	-30	-25	-16	-17	-15	-10	-4	-7	-9	-12	-12	-6	-17

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-3.74	-6.1	-5.65	-1.74	-1.94	-1.67	-1.04	-0.36	-0.57	-1.13	-1.25	-0.69	-0.43	-0.9	-1.93
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	117	186	199	62	43	38	21	13	4	12	5	-2	3	7	63
Low Price	5,343,750	5,653,125	5,625,000	1,012,500	450,000	255,000	41,250	4,687.5	667.5	348.75	371.25	108.75	24.24	23.13	4.09
EV/Sales	11.75	12.82	16.29	8.13	3.65	3.31	3.34	4.44	0.53	40.54	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-8.51	-6.33	-7.05	-4.95	-6.08	-2.35	-1.96	-2.06	-1.26	-1.17	-1.95	-0.87	-0.76	-0.86	-2.36
Price/Earnings High	-15.36	-10.31	-10.98	-9.37	-15.34	-5.28	-4.61	-6.33	-3.11	-1.91	-4.89	-2.8	-1.7	-1.37	-8.03
Price/Earnings Low	-3.46	-4.2	-5.59	-0.97	-1.67	-1.33	-0.48	-0.29	-0.23	-0.5	-0.89	-0.38	-0.23	-0.47	-0.57
Price/Book Value	13.06	29.28	60	-8.94	3.15	2.96	1.33	0.82	8.03	4.5	1.5	1.67	-5.77	-0.76	17.78
Price/Book Value Average	27.77	31.67	58.95	-33.43	9.67	4.72	4.02	4.98	33.26	4.85	3.1	3.51	-10.58	-1.11	23.54
Price/Book Value High	50.12	51.55	91.76	-63.33	24.39	10.6	9.46	15.31	81.96	7.93	7.76	11.26	-23.74	-1.76	80.17
Price/Book Value Low	11.28	21.02	46.7	-6.57	2.65	2.67	0.98	0.71	5.95	2.07	1.42	1.51	-3.2	-0.61	5.68
Price/Tangible Book Value	22.28	74.62	-18.54	-2.68	-51.51	-23.54	9.26	0.89	11.82	5.3	1.56	1.8	-4.41	-0.69	21.59
Price/Tangible Book Value Average	47.36	80.7	-18.22	-10.01	-158.06	-37.51	27.9	5.36	48.96	5.71	3.22	3.79	-8.09	-1.02	28.58
Price/Tangible Book Value High	85.47	131.38	-28.36	-18.97	-398.49	-84.19	65.74	16.48	120.65	9.34	8.07	12.14	-18.16	-1.61	97.34
Price/Tangible Book Value Low	19.24	53.56	-14.43	-1.97	-43.37	-21.2	6.79	0.76	8.77	2.44	1.47	1.63	-2.45	-0.56	6.89
Price/Sales	13	13.03	15.41	6.71	3.3	2.86	2.7	1.44	0.47	29.52	- -	- -	- -	- -	- -
Price/Sales Average	27.63	14.1	15.14	25.09	10.13	4.56	8.14	8.73	1.97	31.81	- -	- -	- -	- -	- -
Price/Sales High	49.87	22.95	23.56	47.53	25.53	10.23	19.19	26.81	4.84	52.02	- -	- -	- -	- -	- -
Price/Sales Low	11.23	9.36	11.99	4.93	2.78	2.58	1.98	1.24	0.35	13.59	- -	- -	- -	- -	- -
Price/Cash Flow	-3.68	-5.87	-5.44	-1.68	-1.88	-1.67	-0.96	-0.36	-0.56	-1.06	-1.23	-0.65	-0.43	-0.72	-1.92
Price/Cash Flow Average	-7.82	-6.35	-5.34	-6.29	-5.77	-2.66	-2.88	-2.17	-2.33	-1.14	-2.54	-1.36	-0.78	-1.06	-2.54
Price/Cash Flow High	-14.11	-10.34	-8.31	-11.91	-14.54	-5.96	-6.79	-6.68	-5.74	-1.87	-6.37	-4.37	-1.76	-1.68	-8.65
Price/Cash Flow Low	-3.18	-4.21	-4.23	-1.24	-1.58	-1.5	-0.7	-0.31	-0.42	-0.49	-1.16	-0.59	-0.24	-0.58	-0.61
Price/Free Cash Flow Average	-7.95	-6.6	-5.55	-6.5	-5.95	-2.66	-3.14	-2.2	-2.36	-1.21	-2.58	-1.45	-0.79	-1.32	-2.55
Price/Free Cash Flow High	-14.34	-10.74	-8.64	-12.32	-15	-5.98	-7.4	-6.75	-5.81	-1.98	-6.46	-4.64	-1.78	-2.08	-8.68
Price/Free Cash Flow Low	-3.23	-4.38	-4.4	-1.28	-1.63	-1.51	-0.76	-0.31	-0.42	-0.52	-1.18	-0.62	-0.24	-0.72	-0.61
EV/Sales Average	26.38	13.89	16.02	26.51	10.48	5	8.78	11.72	4.72	44.03	- -	- -	- -	- -	- -
EV/Sales High	48.62	22.74	24.45	48.94	25.88	10.68	19.82	29.81	12.79	74.84	- -	- -	- -	- -	- -
EV/Sales Low	9.98	9.15	12.88	6.35	3.13	3.02	2.62	4.24	0.19	16.26	- -	- -	- -	- -	- -
EV/EBITDA Average	-8.2	-7.36	-6.16	-6.29	-5.59	-3.07	-3.04	-5.18	-11.95	-1.45	-1.84	-0.53	-0.78	-0.96	-6.1
EV/EBITDA High	-15.1	-12.05	-9.4	-11.61	-13.8	-6.56	-6.86	-13.16	-32.41	-2.46	-6.04	-3.15	-2.18	-1.38	-21.34
EV/EBITDA Low	-3.1	-4.85	-4.95	-1.51	-1.67	-1.86	-0.91	-1.87	-0.48	-0.53	-0.33	0.14	0.01	-0.63	-1.3
EV/EBIT Average	-7.98	-7.12	-5.86	-6.14	-5.32	-2.89	-2.72	-3.99	-9.02	-1.39	-1.78	-0.52	-0.74	-0.9	-5.92
EV/EBIT High	-14.71	-11.66	-8.94	-11.34	-13.15	-6.17	-6.14	-10.15	-24.47	-2.37	-5.85	-3.05	-2.07	-1.3	-20.72
EV/EBIT Low	-3.02	-4.69	-4.71	-1.47	-1.59	-1.75	-0.81	-1.44	-0.36	-0.51	-0.32	0.14	- -	-0.6	-1.26
Last Price	6,187,500	7,875,000	7,228,125	1,378,125	534,375	283,125	56,250	5,437.5	900	757.5	393.75	120	43.75	28.75	12.81
High Price	23,737,500	13,865,625	11,053,125	9,759,375	4,134,375	1,012,500	399,375	101,250	9,187.5	1,335	2,032.5	810	180	66.75	57.75
Enterprise Value Average	264	201	195	201	122	57	56	35	33	13	22	10	10	13	91
Enterprise Value High	486	330	298	372	302	122	127	89	89	23	73	60	28	19	317
Enterprise Value Low	100	133	157	48	36	34	17	13	1	5	4	-3	- -	9	19

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3
Revenue per Share	476,000	604,208.33	469,076.92	205,351.35	161,930.56	98,956.52	20,814.94	3,775.95	1,896.48	25.66	- -	- -	- -	- -	- -
EBITDA per Share	-1,532,238.1	-1,139,750	-1,219,884.62	-865,594.59	-303,625	-161,078.26	-60,168.83	-8,554.43	-748.24	-780.72	-373.2	-272.7	-101.03	-52.04	-4.77
Operating Income per Share	-1,572,952.38	-1,178,625	-1,282,576.92	-886,648.65	-318,805.56	-171,356.52	-67,152.6	-11,091.14	-991.06	-811.72	-385.46	-281.54	-106.03	-55.33	-4.92
Basic EPS, GAAP	-1,545,285.71	-1,344,958.33	-1,006,807.69	-1,041,540.54	-269,513.89	-191,704.35	-86,568.18	-15,992.41	-2,950.41	-697.98	-415.64	-289.58	-105.99	-48.86	-7.19
Basic EPS from Cont Ops	-1,545,285.71	-1,344,958.33	-1,006,807.69	-1,009,945.95	-260,333.33	-191,704.35	-73,655.84	-11,237.97	-889.7	-697.98	-415.64	-289.58	-105.99	-48.86	-7.19
Diluted EPS, GAAP	-1,545,285.71	-1,344,958.33	-1,006,807.69	-1,041,540.54	-269,513.89	-191,704.35	-86,568.18	-15,992.41	-2,950.41	-697.98	-415.64	-289.58	-105.99	-42.13	-7.19
Diluted EPS from Cont Ops	-1,545,285.71	-1,344,958.33	-1,006,807.69	-1,009,945.95	-260,333.33	-191,704.35	-73,655.84	-11,237.97	-889.7	-697.98	-415.64	-289.58	-105.99	-42.13	-7.19
Dividend per Share	- -	- -	- -	- -	1,041.67	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1,682,047.62	-1,341,375	-1,329,346.15	-819,729.73	-284,277.78	-169,852.17	-58,857.14	-15,158.23	-1,600.54	-714.32	-318.89	-185.28	-102.29	-39.73	-6.68
Free Cash Flow per Basic Share	-1,708,714.29	-1,391,541.67	-1,380,076.92	-847,270.27	-292,944.44	-170,434.78	-63,714.29	-15,326.58	-1,618.7	-756.08	-323.36	-196.12	-103.56	-42.34	-6.7
Cash & Equivalents per Share	1,758,190.48	1,071,541.67	596,384.62	395,189.19	199,138.89	109,217.39	31,006.49	6,659.49	1,696.17	463.74	444.87	202.23	48.12	15.29	1.55
Book Value per Share	473,619.05	268,958.33	120,461.54	-154,108.11	169,527.78	95,530.43	42,207.79	6,613.92	112.1	168.42	261.99	71.93	-7.58	-37.94	0.72
Tangible Book Value per Share	277,714.29	105,541.67	-389,807.69	-514,567.57	-10,375	-12,026.09	6,074.68	6,143.04	76.15	142.97	251.76	66.73	-9.91	-41.51	0.59

Plus Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)